Hannover Rueck SE (HNRB) Price & Analysis
HNRB Stock Chart & Stats
- Day’s Range
- EUR 46.80 - EUR 46.80
- 52-Week Range
- EUR 36.80 - EUR 47.00
- Previous Close
- EUR 47.00
- Volume
- 0
- Average Volume (3M)
- 0
- Market Cap
- EUR 34.97B
- Enterprise Value
- EUR 39.33B
- Total Cash (Recent Filing)
- EUR 1.06B
- Total Debt (Recent Filing)
- EUR 4.13B
- Price to Earnings (P/E)
- 3.8
- Beta
- 0.39
- Next Earnings
- Nov 09, 2026
- EPS Estimate
- 0.9
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 4.46%
Bulls Say, Bears Say
Bulls Say
Strong Underwriting Profitability
The combined ratio provides evidence of disciplined pricing, risk selection and claims management. Operating well below target gives Hannover Re resilience against catastrophe volatility and supports durable underwriting profitability.
Robust Capitalization
A high solvency ratio and strong internal capital generation provide substantial capacity to absorb underwriting shocks, support premium growth and maintain strategic flexibility without relying heavily on external funding.
Premium And New Business Growth
Renewal momentum and expanding contractual service margins indicate sustained demand for Hannover Re’s risk-transfer solutions. Growth across P&C and Life & Health can broaden earnings capacity and improve future revenue visibility.
Bears Say
Reinsurance Pricing Is Softening
Lower risk-adjusted prices can compress future underwriting margins, particularly in property catastrophe business. If market competition persists, Hannover Re may need stricter selection or accept slower premium growth to protect returns.
Life & Health Claims And Assumption Volatility
Life & Health profitability depends on long-duration assumptions for morbidity, mortality and claims behavior. Adverse revisions or localized experience can increase reserves and reduce earnings predictability despite portfolio growth.
Inconsistent Operating Profitability And Cash Conversion
Volatile operating margins and weaker free-cash-flow conversion make reported earnings harder to normalize and assess. This may constrain confidence in recurring profitability, especially when claims, reserves and investment results fluctuate.
Hannover Rueck SE News
HNRB FAQ
What was Hannover Rueck SE’s price range in the past 12 months?
What is Hannover Rueck SE’s market cap?
When is Hannover Rueck SE’s upcoming earnings report date?
How were Hannover Rueck SE’s earnings last quarter?
Is Hannover Rueck SE overvalued?
Does Hannover Rueck SE pay dividends?
What is Hannover Rueck SE’s EPS estimate?
How many shares outstanding does Hannover Rueck SE have?
What happened to Hannover Rueck SE’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Hannover Rueck SE?
What is the TipRanks Smart Score and how is it calculated?
Hannover Rueck SE Stock Smart Score
Company Description
Hannover Rueck SE
Hannover Rück SE, through its network of global subsidiaries, functions as a prominent international supplier of extensive reinsurance solutions and related services. Its business operations are primarily divided into two main areas: Property & Casualty Reinsurance and Life & Health Reinsurance. Within the Property & Casualty division, the company delivers a wide array of offerings. These include general property and casualty coverage, bespoke facultative reinsurance, protection against major catastrophic events (known as catastrophe XL), intricate structured reinsurance programs, and innovative insurance-linked securities. Moreover, it devises specialized risk management strategies for specific industries such as agriculture, livestock, and bloodstock; aviation and space endeavors; marine and offshore energy ventures; and complex exposures like credit, surety, and political risks. In the Life & Health sector, Hannover Rück provides reinsurance for various products, including group and individual credit life policies, enhanced annuity options, group life and health plans, and Takaful (Islamic insurance) products. It further extends its expertise to risk solutions concerning critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm also offers a suite of financial solutions. These encompass funding for new business initiatives, unlocking embedded value, providing crucial reserve and solvency relief, and facilitating the divestiture of non-essential business segments. Established in 1966 and based in Hanover, Germany, the company adopted its current name, Hannover Rück SE, in March 2013, having previously been known as Hannover Rückversicherung AG. It operates as a subsidiary of Talanx AG.
- Sector
- Financial
- Industry
- Insurance - Reinsurance
- CEO
- Clemens Jungsthofel
- Employees
- 4,078
- Website
- www.hannover-re.com
- Address
- Karl-Wiechert-Allee 50, Hanover, NI, 30625, DE
Hannover Rueck SE (HNRB) Earnings & Revenues
HNRB Company Deck
HNRB Earnings Call
Earnings Call SentimentPositive
The call conveyed strong operational and financial results: solid group net income (EUR 1.4bn), P&C combined ratio well inside target (83.2%), ROI above target (3.7%), robust solvency (254%) and significant premium/CSM growth across business lines. Management acknowledged market headwinds — notably rate softening (risk-adjusted price decline ~4%), structured reinsurance volume reductions, IFRS 17 reporting effects on revenue, and localized claim/assumption pressures in Life & Health — but emphasized prudent reserving, ample large-loss buffers (~EUR 1.5bn remaining), and confidence in delivering 2026 guidance. Overall, the positives (profitability, capital strength, growth in renewals/CSM and investment yield) outweigh the challenges, with management framing the negatives as manageable and addressed through underwriting discipline and reserve prudence.
View all DE:HNRB earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 2 | 5 |
| Technical Analysis | 3 | 2 | 5 |
| Moving Averages | 12 | 0 | 0 |